#europeanmedicinesagency — Public Fediverse posts

https://www.europesays.com/dk/94000/ France becomes first EU country to reimburse anti-obesity drugs #AntiObesityDrugs #EliLilly #EuropeanMedicinesAgency #EuropeanUnion #France #Mounjaro #NovoNordisk #TF1 #US #Wegovy #WeightLossDrugs

https://www.europesays.com/dk/93980/ France becomes first EU country to reimburse anti-obesity drugs #AntiObesityDrugs #EliLilly #EuropeanMedicinesAgency #EuropeanUnion #France #Mounjaro #NovoNordisk #TF1 #US #Wegovy #WeightLossDrugs

France becomes first EU country to reimburse anti-obesity drugs

France ⁠will reimburse the cost of weight-loss drugs prescribed to severely obese patients from mid-June in a first…
#Europe #EU #Anti-obesitydrugs #EliLilly #EuropeanMedicinesAgency #EuropeanUnion #France #Mounjaro #NovoNordisk #TF1 #US #Wegovy #weight-lossdrugs
https://www.europesays.com/europe/54593/

https://www.europesays.com/dk/91870/ CHMP Backs EU Approval of Novo Nordisk’s Wegovy Pill for Obesity #EuropeanMedicinesAgency #ExcessBodyWeight #NovoNordisk #Obesity #recommendation #Wegovy #WeightLoss #WeightManagement #ZacksInvestmentResearch

https://www.europesays.com/dk/90618/ European medicines regulator recommends approval for Novo’s Wegovy pill #EliLilly #EuropeanMedicinesAgency #FDAApproval #NovoNordisk #OralTreatments #WeightLossDrug

𝗪𝗜𝗞𝗜𝗣𝗘𝗗𝗜𝗔 𝗣𝗜𝗖𝗧𝗨𝗥𝗘 𝗢𝗙 𝗧𝗛𝗘 𝗗𝗔𝗬

✧ Valerian ✧

Valerian (Valeriana officinalis) is a perennial flowering plant in the honeysuckle family, Caprifoliaceae, native to Europe and southwestern Asia. It grows up to 1.5 m tall, with pinnate leaves and clusters of small, sweet-scented pale pink or white flowers that bloom in summer. The plant occurs in meadows, marshes and wet woodla...

#valeriana #europe #asia #valerian #europeanmedicinesagency #wikipedia
https://en.wikipedia.org/wiki/Valerian_(herb)

𝗪𝗜𝗞𝗜𝗣𝗘𝗗𝗜𝗔 𝗣𝗜𝗖𝗧𝗨𝗥𝗘 𝗢𝗙 𝗧𝗛𝗘 𝗗𝗔𝗬

✧ Valerian ✧

Valerian (Valeriana officinalis) is a perennial flowering plant in the honeysuckle family, Caprifoliaceae, native to Europe and southwestern Asia. It grows up to 1.5 m tall, with pinnate leaves and clusters of small, sweet-scented pale pink or white flowers that bloom in summer. The plant occurs in meadows, marshes and wet woodla...

#valeriana #europe #asia #valerian #europeanmedicinesagency #wikipedia
https://en.wikipedia.org/wiki/Valerian_(herb)

𝗪𝗜𝗞𝗜𝗣𝗘𝗗𝗜𝗔 𝗣𝗜𝗖𝗧𝗨𝗥𝗘 𝗢𝗙 𝗧𝗛𝗘 𝗗𝗔𝗬

✧ Valerian ✧

Valerian (Valeriana officinalis) is a perennial flowering plant in the honeysuckle family, Caprifoliaceae, native to Europe and southwestern Asia. It grows up to 1.5 m tall, with pinnate leaves and clusters of small, sweet-scented pale pink or white flowers that bloom in summer. The plant occurs in meadows, marshes and wet woodla...

#valeriana #europe #asia #valerian #europeanmedicinesagency #wikipedia
https://en.wikipedia.org/wiki/Valerian_(herb)

𝗪𝗜𝗞𝗜𝗣𝗘𝗗𝗜𝗔 𝗣𝗜𝗖𝗧𝗨𝗥𝗘 𝗢𝗙 𝗧𝗛𝗘 𝗗𝗔𝗬

✧ Valerian ✧

Valerian (Valeriana officinalis) is a perennial flowering plant in the honeysuckle family, Caprifoliaceae, native to Europe and southwestern Asia. It grows up to 1.5 m tall, with pinnate leaves and clusters of small, sweet-scented pale pink or white flowers that bloom in summer. The plant occurs in meadows, marshes and wet woodla...

#valeriana #europe #asia #valerian #europeanmedicinesagency #wikipedia
https://en.wikipedia.org/wiki/Valerian_(herb)

𝗪𝗜𝗞𝗜𝗣𝗘𝗗𝗜𝗔 𝗣𝗜𝗖𝗧𝗨𝗥𝗘 𝗢𝗙 𝗧𝗛𝗘 𝗗𝗔𝗬

✧ Valerian ✧

Valerian (Valeriana officinalis) is a perennial flowering plant in the honeysuckle family, Caprifoliaceae, native to Europe and southwestern Asia. It grows up to 1.5 m tall, with pinnate leaves and clusters of small, sweet-scented pale pink or white flowers that bloom in summer. The plant occurs in meadows, marshes and wet woodla...

#valeriana #europe #asia #valerian #europeanmedicinesagency #wikipedia
https://en.wikipedia.org/wiki/Valerian_(herb)

Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease

Sanofi Winthrop Industrie Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease Paris, March 31, 20…
#France #FR #Europe #EU #Sanofi #chronicGVHD #clinicalstudies #EuropeanMedicinesAgency #graft-versus-hostdisease #marketingauthorisation #ROCKstar #SorbonneUniversity #stemcelltransplant #systemictherapy #TheEuropeanCommission #treatmentoptions
https://www.europesays.com/france/19451/

Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses

Sanofi Winthrop Industrie Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP …
#France #FR #Europe #EU #Sanofi #AmericanAcademyofNeurology #clinicalstudy #cognitiveimpairment #EuropeanMedicinesAgency #liverenzymeelevations #phase3studies #progressivemultiplesclerosis #tolebrutinib
https://www.europesays.com/france/18870/

EU region sees increase in multinational trial initiation in Q1 2026

The European Commission (EC), the Heads of Medicines Agencies (HMA), and the European Medicines Agency (EMA) are seeing…
#Europe #EU #EuropeanCommission #Clinicaltrials #EMA #EuropeanMedicinesAgency #theEU #TheEuropeanCommission
https://www.europesays.com/europe/49056/

EU advances plans to reduce reliance on drug imports

The European Union (EU) has taken a major step towards ushering in new rules that will safeguard the…
#Europe #EU #criticalmedicine #EuropeanMedicinesAgency #EuropeanParliament #EuropeanUnion #pharmaceuticalproducts #procurementprocedures #SupplyChain #TheEuropeanUnion
https://www.europesays.com/europe/40905/

European Penny Stocks Under €60M Market Cap To Consider

European markets have recently experienced modest gains, with the pan-European STOXX Europe 600 Index benefiting from easing geopolitical…
#Europe #EU #corporateearnings #EarningsGrowth #European #Europeanmarkets #EuropeanMedicinesAgency #FinancialHealth #FinancialHealthRating #MarketCap #Pennystocks #SimplyWallStFinancialHealthRating #StFinancialHealthRating
https://www.europesays.com/europe/39410/

https://www.europesays.com/dk/71965/ Novo Nordisk to showcase Wegovy data at obesity meet #cagrisema #CardiovascularHealthRisks #EuropeanCongressOnObesity #EuropeanMedicinesAgency #istanbul #NovoNordisk #semaglutide #Type2Diabetes #Wegovy #WeightLossDrugs

Norgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union

Approval follows a posi…
#Europe #EU #EuropeanCommission #(Mavorixafor) #CXCR4receptor #EuropeanMedicinesAgency #exceptionalcircumstances #hypogammaglobulinemia #marketingauthorisation #Norgine #Patients #pharmaceuticalcompany #primaryimmunodeficiency #WHIMsyndrome #whitebloodcells
https://www.europesays.com/europe/26264/

https://www.europesays.com/ch/55083/ Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings #ArrowheadPharmaceuticals #BTK #EuropeanMedicinesAgency #Novartis #PharmaceuticalTechnology #Sanofi

European health chief says EU is at ‘a critical point’ in ensuring new drug access

By Maggie Fick BARCELONA, April 22 (Reuters) – Europe is at a critical juncture for ensuring future access…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #criticaljuncture #EmerCooke #Europe #EuropeanMedicinesAgency #Health #patientaccess #Pharmaceuticals #PresidentDonaldTrump #pricingpolicy
https://www.newsbeep.com/us/601178/

European health chief says EU is at ‘a critical point’ in ensuring new drug access

By Maggie Fick BARCELONA, April 22 (Reuters) – Europe is at a critical juncture for ensuring future access…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #criticaljuncture #EmerCooke #Europe #EuropeanMedicinesAgency #Health #patientaccess #Pharmaceuticals #PresidentDonaldTrump #pricingpolicy
https://www.newsbeep.com/us/601178/

European health chief says EU is at ‘a critical point’ in ensuring new drug access

By Maggie Fick BARCELONA, April 22 (Reuters) – Europe is at a critical juncture for ensuring future access…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #criticaljuncture #EmerCooke #Europe #EuropeanMedicinesAgency #Health #patientaccess #Pharmaceuticals #PresidentDonaldTrump #pricingpolicy
https://www.newsbeep.com/us/601178/

European Growth Stocks Insiders Are Betting On

As European markets rally on the back of a U.S.-Iran ceasefire, investor sentiment has been buoyed by optimism…
#Europe #EU #biopharmaceuticalcompany #EarningsGrowth #European #Europeanmarkets #EuropeanMedicinesAgency #growthcompanies #insiderownership #MarketCap #pharmaceuticalcompany #revenuegrowth
https://www.europesays.com/europe/13370/

European Growth Stocks Insiders Are Betting On

As European markets rally on the back of a U.S.-Iran ceasefire, investor sentiment has been buoyed by optimism…
#Europe #EU #biopharmaceuticalcompany #EarningsGrowth #European #Europeanmarkets #EuropeanMedicinesAgency #growthcompanies #insiderownership #MarketCap #pharmaceuticalcompany #revenuegrowth
https://www.europesays.com/europe/12918/

https://www.europesays.com/ie/432904/ the cost of a miracle cancer drug that not everyone can access – The Irish Times #Business #cancer #Éire #EuropeanMedicinesAgency #EuropeanCommission #hse #IE #Ireland #IrishLifeHealth #IrishPharmaceuticalHealthcareAssociationIpha #LayaHealth #NationalCentreForPharmacoeconomicsNcpe #State #swords #US #vhi #VickyPhelan

https://www.europesays.com/dk/58464/ What Novo Nordisk (CPSE:NOVO B)’s Higher-Dose, Lower-Priced Wegovy Move Means For Shareholders #EuropeanMedicinesAgency #NovoNordisk #PricePressure #RevenueGrowth #WegovyInjection

https://www.europesays.com/dk/58155/ Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU #Approval #DeliveryCosts #europe #EuropeanMedicinesAgency #injection #JacobMartin #NovoNordisk #OnlinePharmacies #PrescriptionMedicine #ProductInformation #temperature #WeightManagement #WeightReduction

https://www.europesays.com/dk/58138/ Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU #Approval #DeliveryCosts #europe #EuropeanMedicinesAgency #injection #JacobMartin #NovoNordisk #OnlinePharmacies #PrescriptionMedicine #ProductInformation #temperature #WeightManagement #WeightReduction

Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease

Sanofi Winthrop Industrie Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease Paris, March 31, 2026.…
#Europe #EU #chronicGVHD #clinicalstudies #EuropeanMedicinesAgency #EuropeanUnion #graft-versus-hostdisease #marketingauthorisation #ROCKstar #Sanofi #SorbonneUniversity #stemcelltransplant #systemictherapy #TheEuropeanCommission #treatmentoptions
https://www.europesays.com/europe/2080/

Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis

Oculis Holding AG ZUG, Switzerland, March 31, 2026 (GLOBE NEWSWIRE) — PRIME designation follows recent Breakthrough Thera…
#Europe #EU #BreakthroughTherapy #European #EuropeanMedicinesAgency #FDA #ischemicopticneuropathy #Oculis #opticneuritis #opticneuropathies #OrphanDrug #Privosegtor #unmetneeds
https://www.europesays.com/europe/1844/

Milestone announces acceptance of MAA by EMA for etripamil nasal spray

Milestone Pharmaceuticals (MIST) announced the acceptance of a Marketing Authorization Application, MAA, by the European Medicines Agency, EMA,…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #acceptance #cardiacarrhythmias #EuropeanMedicinesAgency #Health #MilestonePharmaceuticals #MIST #nasalspray
https://www.newsbeep.com/us/393708/

Milestone announces acceptance of MAA by EMA for etripamil nasal spray

Milestone Pharmaceuticals (MIST) announced the acceptance of a Marketing Authorization Application, MAA, by the European Medicines Agency, EMA,…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #acceptance #cardiacarrhythmias #EuropeanMedicinesAgency #Health #MilestonePharmaceuticals #MIST #nasalspray
https://www.newsbeep.com/us/393708/

Milestone announces acceptance of MAA by EMA for etripamil nasal spray

Milestone Pharmaceuticals (MIST) announced the acceptance of a Marketing Authorization Application, MAA, by the European Medicines Agency, EMA,…
#NewsBeep #News #Medication #acceptance #AU #Australia #cardiacarrhythmias #EuropeanMedicinesAgency #Health #MilestonePharmaceuticals #MIST #nasalspray
https://www.newsbeep.com/au/398211/

https://www.europesays.com/ie/272824/ Milestone announces acceptance of MAA by EMA for etripamil nasal spray #acceptance #CardiacArrhythmias #Éire #EuropeanMedicinesAgency #Health #IE #Ireland #Medication #MilestonePharmaceuticals #MIST #NasalSpray

https://www.europesays.com/uk/680675/ Milestone announces acceptance of MAA by EMA for etripamil nasal spray #acceptance #CardiacArrhythmias #EuropeanMedicinesAgency #Health #Medication #MilestonePharmaceuticals #MIST #NasalSpray #UK #UnitedKingdom

https://www.europesays.com/uk/665964/ Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism #CorceptTherapeutics #EuropeanMedicinesAgency #FoodAndDrugAdministration #Health #HormoneCortisol #hypercortisolism #Medication #NeurologicDisorders #NewDrugApplication #OvarianCancer #patients #UK #UnitedKingdom

Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism

REDWOOD CITY, Calif., December 31, 2025–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage compan…
#NewsBeep #News #Medication #CA #Canada #CorceptTherapeutics #EuropeanMedicinesAgency #foodanddrugadministration #Health #hormonecortisol #hypercortisolism #neurologicdisorders #NewDrugApplication #OvarianCancer #patients
https://www.newsbeep.com/ca/379748/

Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism

REDWOOD CITY, Calif., December 31, 2025–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage com…
#NewsBeep #News #Medication #AU #Australia #CorceptTherapeutics #EuropeanMedicinesAgency #foodanddrugadministration #Health #hormonecortisol #hypercortisolism #neurologicdisorders #NewDrugApplication #OvarianCancer #patients
https://www.newsbeep.com/au/382911/

https://www.europesays.com/ie/260028/ Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism #CorceptTherapeutics #Éire #EuropeanMedicinesAgency #FoodAndDrugAdministration #Health #HormoneCortisol #hypercortisolism #IE #Ireland #Medication #NeurologicDisorders #NewDrugApplication #OvarianCancer #patients

https://www.europesays.com/ie/230274/ Hair-loss drug boosts hair growth by 539% – Irish study #baldness #CosmoPharmaceuticals #DrMariaHordinsky #Éire #EuropeanMedicinesAgency #GiovanniDiNapoli #HairLoss #Health #IE #Ireland #Medication #SCALP1 #SCALP2 #UniversityOfMinnesota #USFoodAndDrugAdministration

Harmonisation health technology assessments, a slow roll in right direction https://www.euractiv.com/section/health-consumers/news/harmonisation-health-technology-assessments-a-slow-roll-in-right-direction/?utm_source=dlvr.it&utm_medium=mastodon #Austria #Czechia #EuropeanMedicinesAgency

Slovak backlash against Kotlár pandemic investigation riddled with disinformation https://www.euractiv.com/section/health-consumers/news/slovak-backlash-against-pandemic-investigation-riddled-with-disinformation/?utm_source=dlvr.it&utm_medium=mastodon #COVID #EuropeanMedicinesAgency #PeterKotlár #RobertFico #Slovakia

Mpox vaccine for adolescents and eight new medicines receive EMA approval  https://www.euractiv.com/section/health-consumers/news/mpox-vaccine-for-adolescents-and-eight-new-medicines-receive-ema-approval/?utm_source=dlvr.it&utm_medium=mastodon #cancer #EMA #EuropeanMedicinesAgency #medicines #mpox

Patients protest against possible withdrawal of rare liver disease medicine https://www.euractiv.com/section/health-consumers/news/patients-protest-against-possible-withdrawal-of-rare-liver-disease-medicine/?utm_source=dlvr.it&utm_medium=mastodon #CHMP #EASL #EMA #EuropeanMedicinesAgency #liver

Patients protest against possible withdrawal of rare liver disease medicine https://www.euractiv.com/section/health-consumers/news/patients-protest-against-possible-withdrawal-of-rare-liver-disease-medicine/?utm_source=dlvr.it&utm_medium=mastodon #CHMP #EASL #EMA #EuropeanMedicinesAgency #liver

Patients protest against possible withdrawal of rare liver disease medicine https://www.euractiv.com/section/health-consumers/news/patients-protest-against-possible-withdrawal-of-rare-liver-disease-medicine/?utm_source=dlvr.it&utm_medium=mastodon #CHMP #EASL #EMA #EuropeanMedicinesAgency #liver

Swedish medicine safety expert to head EMA’s pharmacovigilance committee [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/swedish-medicine-safety-expert-to-head-emas-pharmacovigilance-committee/?utm_source=dlvr.it&utm_medium=mastodon #EuropeanMedicinesAgency #medicines #Pharmacovigilance #Sweden

EMA safety committee suspend medicine for premature birth https://www.euractiv.com/section/health-consumers/news/ema-safety-committee-suspend-medicine-for-premature-birth/?utm_source=dlvr.it&utm_medium=mastodon #EuropeanMedicinesAgency #hydroxyprogesteronecaproate #progestin

Europe’s healthcare ambitions: right diagnosis, wrong treatment [Promoted content] https://www.euractiv.com/section/health-consumers/opinion/europes-healthcare-ambitions-right-diagnosis-wrong-treatment/?utm_source=dlvr.it&utm_medium=mastodon #EuropeanMedicinesAgency #Health #medicine #patients #promoted

Lawmakers reach speedy provisional deal on European Medicines Agency fees https://www.euractiv.com/section/health-consumers/news/lawmakers-reach-speedy-provisional-deal-on-european-medicines-agency-fees/?utm_source=dlvr.it&utm_medium=mastodon #CristianSilviuBușoi #EMAfees #EuropeanMedicinesAgency

MEPs give green light to EU Medicines Agency’s new fee system https://www.euractiv.com/section/health-consumers/news/meps-give-green-light-to-eu-medicines-agencys-new-fee-system/?utm_source=dlvr.it&utm_medium=mastodon #EMA #EuropeanMedicinesAgency #pharmaindustry #Scientificresearch